Sign in

hideta77.bsky.social

@hideta77.bsky.social
13 followers 18 following 5 posts
PostsRepliesMedia
Reposted by @hideta77.bsky.social
Clinical Infectious Diseases @cidjournal.bsky.social · 08/09/2026
Small Mean Differences May Hide a Vulnerable Subgroup: Frailty and Quality of Life in Aging People With HIV ✅ Just Accepted 🔗 bit.ly/4ici9th
041
hideta77.bsky.social @hideta77.bsky.social · 08/08/2026
📢 New in HIV Medicine: our multicentre study of physical frailty among 325 people with HIV across 8 centres in Japan. 69.8% were prefrail and 8.6% frail; frailty was associated with depressive symptoms and polypharmacy. onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Frailty and associated clinical factors among Japanese people with <fc>HIV</fc>: A multicentre cross‐sectional study using the revised Japanese Cardiovascular Health Study criteria
Objectives Frailty is relevant to HIV care across middle and later life, yet Japanese data remain limited. We evaluated frailty, prefrailty and associated factors in Japanese people with HIV using t.....
100
Reposted by @hideta77.bsky.social
European AIDS Clinical Society @eacsociety.bsky.social · 15/10/2025
#EACS2025 - Toshibumi Taniguch from #Japan is talking about #HIV and #Virology. Reservoir persistence remains the major obstacle. The capsid inhibitors and long-acting agents expand suppression strategies.
163
Reposted by @hideta77.bsky.social
European AIDS Clinical Society @eacsociety.bsky.social · 30/09/2025
👩‍⚕️👨‍🔬 Why do people attend #EACS2025? Hear it straight from previous participants! Watch their testimonials and see why Paris is the place to be this October. 🌟 Register now and join the global conversation on HIV: loom.ly/cOdLETc #HIV #EACS2025 #Paris #MedicalCommunity
001
hideta77.bsky.social @hideta77.bsky.social · 29/09/2025
www.youtube.com/watch?v=-1rP...
youtube.com
20th European AIDS Conference I Hear from the participants!
YouTube video by European AIDS Clinical Society
000
hideta77.bsky.social @hideta77.bsky.social · 13/08/2025
Pleased to inform that a consortium of Japanese doctors has published a paper on LAI. I’m honored to be listed as a co-author. Prof. Orkin encouraged us to form the consortium. We appreciate your support. @profchloeorkin.bsky.social @toshtaniguc.bsky.social onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics
Objectives Long-acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real-world data in East Asia remain scarce. This study aims to evaluate the impact of ...
031